아젠다

첫째날 2019년 11월 13일(수)

8:15

Conference Registration and Welcome Refreshments

8:45

Co-Chairs’ Welcome and Opening Remarks

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

크로스 인더스트리 스포트라이트 담화 국제적 사업의 어두운 면과 조직을 보호하기 위한 단계

IN CONVERSATION WITH:

Richard Bistrong
CEO
Front-Line Anti-Bribery LLC;
Former FCPA Violator and FBI/UK Cooperator

INTERVIEWED BY:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

9:45

패널 디스커션 리스크가 높은 사업 - 제3자기관과의 관계가 귀사의 평판에 영향을 미칠 가능성

PANELISTS

Evgeny Tilezhinsky
Global Expansion Business Partner, Office of Business
Integrity and Ethics
Vertex Pharmaceuticals

Niels Wohlwend
Senior Director HCC Europe & Canada, Global Compliance Group
Celgene

10:30

Networking and Refreshment Break

11:00

세계 시장의 투명성과 공시

Munish Duvedi
Consultant
GCO Global

Klaus Geldsetzer
Chief Compliance Officer EMEA
Santen GmbH

12:00 Leadership Summit

법 및 컴플라이언스 리더십 서밋

2019년 테마: 롤모델로서의 컴플라이언스

13:15 Summit Host Welcome

This summit is designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing heads of compliance across the life sciences industry. The host facilitates discussions surrounding key questions, challenges and issues. Participants benefit from exclusive networking with peers, sharing concerns and acquiring additional best practices for enriching their compliance programmes.

DIALOGUE DRIVERS:

I.Essential Skills of a Compliance Manager
II.Why Friction and How to Handle Friction
III.Why Ethics?
IV.KPIs…for Whom?
V.Who Owns Ethics & Compliance?

SUMMIT LEADER:

Michaela Ahlberg
Chief Ethics & Compliance Officer
Getinge

14:45

Close of Leadership Summit & Return to General Sessions

*Participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the conference). Final eligibility approval is at the discretion of CBI.

12:00

Networking Luncheon

13:15

한정된 자원에 의한 단기 집중적 리스크의 평가와 완화책

Dumitru Uta
Ethics and Compliance Director
Lilly South-East Europe

14:00

GDPR 벤치마킹 GDPR이 적용되어 18개월간 얻은 정보

James Clark
Senior Associate
DLA Piper

14:45

Networking and Refreshment Break

15:15

온라인에 의한 컴플라이언스 강화 트레이닝의 전송

Richard Hodgins
Chief Technology Officer
Intuition(invited)

16:00

패널 디스커션 5G 시대의 법에 준거한 디지털 커뮤니케이션 구축

PANELISTS:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Ursula Hohlneicher
General Manager Compliance
AstraZeneca

17:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

둘째날 2019년 11월 14일(목)

8:15

Morning Refreshments

8:45

Co-Chairs’ Review of Day One

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

전문가 Q&A 입문자 및 전문가용 컴플라이언스 - 알아야 할 정보와
사전에 알면 좋을 것으로 생각되는 정보

INTERVIEW WITH:

Alessandra Hawthorne
Head, Corporate Department Ethics & Compliance,
Global Chief Ethics and Compliance Officer
Boehringer Ingelheim

INTERVIEWED BY:

John P. Oroho
Principal
Porzio, Bromberg & Newman;
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

10:00

공동 발표EU 내부고발자 보호법의 영향을 검증

David Eves
Head of Compliance
Chugai Pharma Europe Ltd

Gareth Rees
Partner, Special Matters and Government Investigations
King & Spalding

10:45

Networking and Refreshment Break

11:15

인사이트풀 디스커션맞벌이 - 환자의 권리 확보, 환자의 소리 통합

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Kim Smith
Compliance Manager, UK and Ireland
Merck Group

12:00

Networking Luncheon

13:00

진화하는 에코시스템에서 데이터 분석을 이용한 세계의 감시

Speaker TBA

13:45

HCP용 스폰서십 및 보조금 관리에 대한 전략의 비교

Ariadna Quesada
Compliance Director, EMEA
HillRom

14:30

Close of Conference

* 不測の事態により、事前の予告なしにプログラムが?更される場合があります。